Search research articles
Contact Us
Filters
Showing results (241-250 of 401) with videos related to
Page
of 41
Sort By:
Iscience
|
September 18, 2023
CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca<sup>2+</sup> oscillations and NF-κB/MAPK signaling pathways
Minglian Xu, Dezhi Song, Xiaoxiao Xie, et al.
Plos One
|
April 18, 2012
Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption
An Qin, Tak S Cheng, Zhen Lin, et al.
Cell Death & Disease
|
September 17, 2020
PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling
Shangfu Li, Qiuli Liu, Depeng Wu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 24, 2006
Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL
Catherine Middleton-Hardie, Qing Zhu, Harry Cundy, et al.
FEBS Letters
|
November 26, 2013
HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation
Xinghuo Wu, Shek Man Chim, Vincent Kuek, et al.
Journal of Cellular Physiology
|
November 4, 2014
Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity
Jun Yao, Jia Li, Lin Zhou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype
Sarah L Rea, John P Walsh, Lynley Ward, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 27, 2019
Cumambrin A prevents OVX-induced osteoporosis <i>via</i> the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways
Lin Zhou, Qian Liu, Guoju Hong, et al.
Journal of Cellular Physiology
|
May 5, 2007
Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL)
Estabelle S M Ang, Ping Zhang, James H Steer, et al.
Plos One
|
November 4, 2021
The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function
Melanie A Sultana, Carmel Cluning, Wai-Sin Kwong, et al.
Page
of 41
Search research articles
Search
Showing results (241-250 of 401) with videos related to
Sort By:
Page
of 41
Iscience
|
September 18, 2023
CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca<sup>2+</sup> oscillations and NF-κB/MAPK signaling pathways
Minglian Xu, Dezhi Song, Xiaoxiao Xie, et al.
Plos One
|
April 18, 2012
Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption
An Qin, Tak S Cheng, Zhen Lin, et al.
Cell Death & Disease
|
September 17, 2020
PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling
Shangfu Li, Qiuli Liu, Depeng Wu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 24, 2006
Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKL
Catherine Middleton-Hardie, Qing Zhu, Harry Cundy, et al.
FEBS Letters
|
November 26, 2013
HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation
Xinghuo Wu, Shek Man Chim, Vincent Kuek, et al.
Journal of Cellular Physiology
|
November 4, 2014
Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity
Jun Yao, Jia Li, Lin Zhou, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 4, 2006
A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype
Sarah L Rea, John P Walsh, Lynley Ward, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 27, 2019
Cumambrin A prevents OVX-induced osteoporosis <i>via</i> the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways
Lin Zhou, Qian Liu, Guoju Hong, et al.
Journal of Cellular Physiology
|
May 5, 2007
Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL)
Estabelle S M Ang, Ping Zhang, James H Steer, et al.
Plos One
|
November 4, 2021
The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function
Melanie A Sultana, Carmel Cluning, Wai-Sin Kwong, et al.
Page
of 41